ESCALON MEDICAL CORP vs. Microsoft Corporation
ESCALON MEDICAL CORP and Microsoft Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ESMC | MSFT | |
|---|---|---|
| Market Cap | — | $3.74 trillion |
| Revenue (TTM) | — | $331.84 billion |
| Net Income (TTM) | — | $133.75 billion |
ESMC and MSFT split the size & scale factors evenly.
Valuation
| ESMC | MSFT | |
|---|---|---|
| P/E Ratio | — | 28.07 |
| Price / Book | — | 8.46 |
| Price / Sales | — | 11.27 |
ESMC and MSFT split the valuation factors evenly.
Profitability
| ESMC | MSFT | |
|---|---|---|
| Net Margin | — | 40.31% |
| Return on Equity | — | 30.23% |
ESMC and MSFT split the profitability factors evenly.
Dividend
| ESMC | MSFT | |
|---|---|---|
| Dividend Yield | — | 0.72% |
| Payout Ratio | — | 20.28 |
ESMC and MSFT split the dividend factors evenly.
Risk & Sentiment
| ESMC | MSFT | |
|---|---|---|
| Short Interest | — | 0.54% |
ESMC and MSFT split the risk & sentiment factors evenly.
Dig deeper: ESMC overview, ESMC financials, MSFT overview, MSFT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.